Insmed Incorporated Reports Positive Phase 3b Resu...
Category : Clinical Trial Update 26 March 2026A potential shift is underway in how Mycobacterium avium complex (MAC) lung disease is treated. I...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Complement Therapeutics GmbH Doses First Patient i...
Category : Clinical Trial Update 26 March 2026A new gene therapy approach is entering human trials—targeting one of the most challenging eye...
BrightGene Bio-Medical Technology Co., Ltd. Report...
Category : Clinical Trial Update 26 March 2026The obesity drug race just got more crowded—and more competitive. BrightGene has announced pos...
VERIGRAFT Advances into Pivotal Trial for Regenera...
Category : Clinical Trial Update 26 March 2026A small biotech is making a big bet on curative vascular medicine. VERIGRAFT has initiated a pivotal...
Everest Medicines Acquires Rights to Cardamyst Nas...
Category : Licensing/Collaboration Deal 25 March 2026A strategic deal is reshaping the cardiovascular treatment landscape in China. Everest Medicines has...
Latest Newsletter Post
-
VERIGRAFT Advances into Pivotal Tri..
26 March 2026
-
BrightGene Bio-Medical Technology C..
26 March 2026
-
Complement Therapeutics GmbH Doses..
26 March 2026
-
Insmed Incorporated Reports Positiv..
26 March 2026
-
Pfizer & Valneva Report Phase 3 Res..
25 March 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com